–
Mineralys Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.7
FY22:
−31.5
FY23:
−84.7
FY24:
−192
FY25:
−171
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.7
FY22:
−31.5
FY23:
−84.7
FY24:
−192
FY25:
−171
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.4
FY22:
−29.8
FY23:
−71.9
FY24:
−178
FY25:
−155
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.4
FY22:
−29.8
FY23:
−71.9
FY24:
−178
FY25:
−155
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.